MarketCatalyst
← Back to Resources
MARKETCATALYST

Anthropic's $1.4T IPO Leaves Chinese, Hong Kong Investors Out in the Cold

Banks running Anthropic's initial public offering are refusing orders from some mainland Chinese and Hong Kong institutions, or warning them not to expect shares, amid U.S. national-security concerns, Bloomberg reports. Some investors are trying offshore trusts and swaps instead, ahead of a Nov. 18 pricing.

Published Nov. 13, 2026 · 11:00 a.m. ET · 2 min read

Institutional investors from mainland China and Hong Kong are being kept out of Anthropic's planned $1.4 trillion initial public offering, Bloomberg reports, with some banks refusing their orders and others warning that allocations are unlikely amid U.S. national-security concerns. The Claude maker is set to price the deal on Nov. 18 and begin trading on Nasdaq under the ticker ANT on Nov. 19.

$1.4T
Top-end valuation on a fully diluted basis
~6x
Reported demand versus shares available in the IPO
$90.4B
Maximum raised via the IPO and a private placement

The deal at a glance

ItemDetail
Price range$70–$78 per share
Shares offered825M Class A shares
IPO proceedsUp to $64.35B
Private placement$26B
ValuationAbout $1T on shares outstanding, up to $1.4T fully diluted
Pricing / first tradeNov. 18 / Nov. 19, Nasdaq (ANT)
Lead banksGoldman Sachs, Morgan Stanley

By our calculation, the $64.35 billion public offering and the $26 billion private placement together come to about $90.4 billion.

Who is being left out

  • Banks say no. Some underwriters are turning away orders from mainland Chinese and Hong Kong institutions, while others accept the orders but warn that shares are unlikely to be allocated.
  • The rules cited. Some banks point to U.S. defense-trade rules known as ITAR. Anthropic's prospectus does not explicitly bar investors from China or Hong Kong.
  • Workarounds. Investors are exploring offshore trusts, special-purpose vehicles and swaps. One Chinese tech founder's family office is bidding through a British Virgin Islands trust but has no confirmed allocation.

Why the sensitivity

  • A precedent. SpaceX's record IPO earlier this year also restricted Chinese and Hong Kong investors, though they could buy the shares once they began trading.
  • No Claude in China. Anthropic's Claude products are not available in mainland China or Hong Kong.
  • Security backdrop. Anthropic's dispute with the Pentagon over a supply-chain-risk designation, along with wider U.S.-China tension over AI, adds regulatory sensitivity to the deal.

What to watch

  • Final pricing on Nov. 18. With demand reported at about six times the shares on offer, whether the deal prices at or above the top of the $70–$78 range.
  • First-day trading. Chinese and Hong Kong investors shut out of the IPO may still be able to buy once shares list on Nov. 19.
  • Regulators. Any U.S. guidance on foreign investor access to AI company listings.

This article is informational only and is not investment advice.

Readers also read

MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.

Anthropic's $1.4T IPO Leaves Chinese